Immune-stimulating complexes (iscoms) have been prepared containing the major S gene products (HBsAg) of the hepatitis B virus genome. Immunization of B ALB/c mice with a single dose of hepatitis B iscoms in saline resulted in a high titre antibody response to HBsAg. In contrast, the original HBsAg preparation required an adjuvant to produce equivalent amounts of antibody. Analysis of sera from mice immunized with hepatitis B iscoms revealed antibodies directed against the major a determinants of HBsAg. High secondary antibody responses were observed in immunized animals previously inoculated with a sub-immunogenic dose of HBsAg indicating that hepatitis B iscoms may represent a suitable immunogen for use in individuals in whom a course of immunization with currently licensed hepatitis B vaccines has failed to produce a significant anti-HBs response.
BradfordM. M.1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
BrownS. E.,
HowardC. R.,
ZuckermanA. J.,
StewardM. W.1984; The determination of the affinity of antibodies to hepatitis B surface antigen. Journal of Immunological Methods 72:41–48
BrownS. E.,
StanleyC.,
HowardC. R.,
ZuckermanA. J.,
StewardM. W.1986; Antibody responses to recombinant and plasma derived hepatitis B vaccines. British Medical Journal 292:159–161
HanataniM.,
NishifujiK.,
FutaiM.,
TsuchiyaT.1984; Solubilization and reconstitution of membrane proteins of Escherichia coliusing alkanoyl-N-methylglucamides. Journal of Biochemistry 95:1349–1353
HildrethJ. E. K.1982; N-d-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochemical Journal 207:363–366
HillemanM. R.,
BuynakE. B.,
McaleerW. J.,
McleanA. A.,
ProvostP. J.,
TytellA. A.1982; Hepatitis A and hepatitis B vaccines. In Viral Hepatitis pp 385–397SzmunessW.,
AlterH. J.,
MaynardJ. E.
Edited by Philadelphia: Franklin Institute Press;
HowardC. R.,
SkellyJ.,
TaborE.,
GeretyR. J.,
KremastinouJ.,
ZuckermanA. J.1982; The development arid properties of alternative hepatitis B polypeptide vaccines. In Viral Hepatitis pp 411–423AlterH.,
MaynardJ.,
SzmunessW.
Edited by Philadelphia: Franklin Institute Press;
HowardC. R.,
YoungP. R.,
LeeS.,
DixonJ.,
ZuckermanA. J.1986; Hepatitis B surface antigen polypeptide micelles from antigen expressed in Saccharomyces cerevisiae
. Journal of Virological Methods 14:25–35
MilichD. R.,
ThorntonG. B.,
NeurathA. R.,
KentS. B.,
MichelM-L.,
TiollaisP.1985; Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228:1195–1198
OsterhausA.,
WeijerK.,
UytdenhaagF.,
JarrettO.,
SundquistB.,
MoreinB.1985; Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. Journal of Immunology 135:591–596
SkellyJ.,
HowardC. R.,
ZuckermanA. J.1979; Analysis of hepatitis B surface antigen components solubilized with Triton X-100. Journal of General Virology 44:679–689
StevensC.,
AlterH.,
TaylorP.,
ZangE.,
HarleyE.,
SzmuneesW.1984; Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. New England Journal of Medicine 311:496–501
SzmunessW.,
StevensC. E.,
HarleyE. J.,
ZangE. A.,
OleskoW. R.,
WilliamD. C.,
SadovskyR.,
MorrisonJ. M.,
KellnerA.1980; Demonstration of efficacy in a controlled clinical trial in high risk population in the United States. New England Journal of Medicine 303:833–841
SzmunessW.,
StevensC. E.,
HarleyE. J.,
ZangE. A.,
AlterH. J.,
TaylorP. E.,
DeveraA.,
ChenG.-T.-S.,
KellserA.1982; Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype crossprotection. New England Journal of Medicine 307:1481–1486
TaborE.,
HowardC. R.,
SkellyJ.,
GoudeauA.,
ZuckermanA. J.,
GeretyR. J.1982; Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virions. Journal of Medical Virology 10:65–74
WamplerD. E.,
LehmanE. D.,
BogerI.,
McAleerW. J.,
ScolnickE. M.1985; Multiple chemical forms of hepatitis B surface antigen produced in yeast. Proceedings of the National Academy of Sciences U.S.A.: 826830–6834
YoungP. R.,
VaudinM.,
DixonI.,
ZuckermanA. I.1982; Preparation of hepatitis B polypeptide micelles from human carrier plasma. Journal of Virological Methods 4:177–185
ZuckermanA. J.1982; Primary hepatocellular carcinoma and hepatitis B virus. Transactions of the Royal Society of Tropical Medicine and Hygiene 76:711–718